Recent blog posts
GRIA2 Biologics Sequence Review Report 2026: Glutamate receptor 2 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GRIA2 Biologics Sequence Review Report 2026: Glutamate receptor 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GRIA2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GRIA1 Biologics Sequence Review Report 2026: Glutamate receptor 1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GRIA1 Biologics Sequence Review Report 2026: Glutamate receptor 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GRIA1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GRIA3 Biologics Sequence Review Report 2026: Glutamate receptor 3 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GRIA3 Biologics Sequence Review Report 2026: Glutamate receptor 3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GRIA3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GLRA3 Biologics Sequence Review Report 2026: Glycine receptor subunit alpha-3 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GLRA3 Biologics Sequence Review Report 2026: Glycine receptor subunit alpha-3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GLRA3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GLRB Biologics Sequence Review Report 2026: Glycine receptor subunit beta Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GLRB Biologics Sequence Review Report 2026: Glycine receptor subunit beta Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GLRB protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GLRA1 Biologics Sequence Review Report 2026: Glycine receptor subunit alpha-1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GLRA1 Biologics Sequence Review Report 2026: Glycine receptor subunit alpha-1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GLRA1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GLRA2 Biologics Sequence Review Report 2026: Glycine receptor subunit alpha-2 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GLRA2 Biologics Sequence Review Report 2026: Glycine receptor subunit alpha-2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GLRA2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GABRR3 Biologics Sequence Review Report 2026: Gamma-aminobutyric acid receptor subunit rho-3 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GABRR3 Biologics Sequence Review Report 2026: Gamma-aminobutyric acid receptor subunit rho-3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GABRR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GALR1 Biologics Sequence Review Report 2026: Galanin receptor type 1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GALR1 Biologics Sequence Review Report 2026: Galanin receptor type 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GALR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GALR3 Biologics Sequence Review Report 2026: Galanin receptor type 3 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GALR3 Biologics Sequence Review Report 2026: Galanin receptor type 3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GALR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GFRA1 Biologics Sequence Review Report 2026: GDNF family receptor alpha-1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GFRA1 Biologics Sequence Review Report 2026: GDNF family receptor alpha-1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GFRA1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GABRB3 Biologics Sequence Review Report 2026: Gamma-aminobutyric acid receptor subunit beta-3 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GABRB3 Biologics Sequence Review Report 2026: Gamma-aminobutyric acid receptor subunit beta-3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GABRB3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →